A reasonable chance it could cause serious harm or death.
Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.
| Brand name | EPINEPHRINE |
| Generic name | EPINEPHRINE |
| Active ingredient(s) | EPINEPHRINE |
| Distributed by / for | American Regent, Inc. |
| NDC | 0517-3030-01 |
| Full product label | Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous Infusion, intramuscular and Subcutaneous Use, AMERICAN REGENT INC., SHIRLEY, NY 11967. NDC 0517-3030-01 |
| Recalling firm | American Regent, Inc. |
| Distribution | Nationwide within the U.S.A |
| Quantity | 31,935 30mL-vials |
| Recall initiated | 2026-08-11 |
| Report date | 2026-09-16 |
| Recall completed | — |
| Recall number | D-0865-2026 |
| Classification | Class I |
| FDA status | Ongoing |
| Origin on file | Shirley NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗